Liraglutide
Liraglutide for Diabetes Control
A proven therapy for improving blood sugar levels in type 2 diabetes.
Liraglutide for Weight Loss
Clinically effective in supporting long-term sustainable weight loss.
Liraglutide's Health Benefits
Enhancing glycemic control and promoting overall metabolic health.
Advancing Liraglutide Treatment
Partner with us to improve patient outcomes in diabetes and obesity.
Pal-Glu(OSu)-OH
Pal-Glu(OSu)-OH, or Nε-palmitoyl-L-glutamic acid γ-succinimide, is an important intermediate used in the synthesis of lipidated peptides, particularly those intended for pharmaceutical applications. The palmitoyl group at the Nε position enhances the lipophilicity of the compound, which in turn improves the stability and tissue-targeting properties of the resulting peptides. This modification plays a crucial role in the development of long-acting peptide therapeutics.
This compound is commonly used in the preparation of GLP-1 receptor agonists and other peptide-based drugs, with applications in the treatment of type 2 diabetes, obesity, and metabolic disorders. The γ-succinimide group enables efficient conjugation to various bioactive molecules, contributing to the development of sustained-release formulations.
CAS No: 294855-91-7
>>Download COA
Application:
- Peptide Synthesis: Used in the synthesis of lipid-modified peptides, particularly for diabetes and obesity treatments.
- Pharmaceutical Development: Essential in the creation of long-acting peptide-based therapeutics.
- Drug Delivery: Enhances the stability and bioavailability of peptides by improving their solubility and targeting ability.
- Biochemical Research: Investigated for use in modifying peptide properties and improving therapeutic efficacy.
Packing: Customized
Need more information/samples?